ClinicalTrials.gg
RecruitingNCT068262877T-ATHENAUpdated Feb 13, 2025

7T Anatomo-functional Characterization of Structures in the Action Observation Network

An observational study in Brain Function and Cerebral Palsy, sponsored by IRCCS Fondazione Stella Maris. Recruiting at 2 sites in Italy. Open to participants aged 11 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-02-13.

Sponsored by IRCCS Fondazione Stella Maris · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Aug 2025, 1 year 3 months ago, but the record still lists the study as recruiting.
  • Started Dec 2024; still recruiting 1 year 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
40
Ages
11 Years to 40 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 16 studies in Cerebral Palsy by IRCCS Fondazione Stella Maris — 10 open to participants now, 10 under way, none of them phase 3. Cerebral Palsy · IRCCS Fondazione Stella Maris.

Started
2024
with 2 others
Observational
8 of 16
6 open now
Registered
12th of 16
by date

Among the 16 studies in Cerebral Palsy by IRCCS Fondazione Stella Maris, this one is one of 3 that started in 2024, is one of 8 observational ones, and was the 12th registered.

Cerebral Palsy

1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.

Browse Cerebral Palsy studies →

Open to participants now

10 of the 16 studies in Cerebral Palsy by IRCCS Fondazione Stella Maris are open now, in 2 countries. Recruiting first, the newest first:

4 more — sign in →

By country, each count listing its studies:

All 10 open studies →

Where they have run

Who these studies take

Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.

This study: 11 Years to 40 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 16 studies in Cerebral Palsy by IRCCS Fondazione Stella Maris, or all of them as a file.
02

Study summary

The goal of this study is to explore the anatomical-functional characteristics of the AON circuit (with particular interest for subcortical areas and the cerebellum), and the cortico-subcortical connectivity of the nodes of the AON circuit, using an ultra-high field (7T), high spatial resolution Magnetic Resonance Imaging protocol.

The main questions it aims to answer are:

  • Can we demonstrate the involvement of subcortical areas and cerebellum in the AON circuit in each single-subject?
  • Can we obtain similar results in a small group of patients with Cerebral Palsy (CP), in order to demonstrate the feasibility of this approach for the study of the mechanisms of AON reorganization, after early brain damage?
  • Are different patterns of functional activation correlated to different clinical characteristics of CP patients?

Participants will perform a 7 Tesla MRI scan, with a functional and anatomical dedicated protocol and will have a comprehensive clinical assessment before the MRI exam.

Read the detailed description

In healthy humans, brain functional representation of actions, either executed or observed, relies on the human action observation network (AON). Several studies demonstrated that AON activation is crucial for action understanding and for subserving imitation by observation of new motor skills. The demonstration of the activation of this circuit in patients with motor disorders have opened the way to new rehabilitation protocols based on the observation of meaningful actions followed by their execution (Observation to Imitate), often referred as Action Observation Therapy (AOT). In the last decade, AOT was widely used in adult stroke patients as well as in children with cerebral palsy (CP). Overall, these studies demonstrate a significant motor improvement after therapy, that is maintained at follow-up.

Functional Magnetic Resonance Imaging (fMRI) studies on the effects of AOT found a positive correlation between the functional improvements of manual abilities of these patients and the enlargement of movement-related brain regions, suggesting that AOT can promote the activation of mechanisms of brain plasticity and functional reorganization of the cortical areas responsible for movements. Recently, fMRI studies have demonstrated that also other brain regions, such as the cerebellum, the thalamus and the basal ganglia, belong to the AON.

Despite numerous studies on AON, the fine-grained details of this complex network, especially at subcortical level, and the reciprocal interactions between different brain regions are largely unknown. Moreover, no studies are available at submillimeter level concerning the involvement of subcortical structures. Compared with lower magnetic field systems, Ultra-High Field Magnetic Resonance (UHF-MR) permits a remarkable gain in terms of signal to noise ratio (SNR). This significant increase in SNR produces a great improvement of all imaging parameters, and can be exploited increasing spatial and/or temporal resolution. Moreover, at 7T, we assist also to an empowered sensitivity of the signal to modifications of the composition of tissue that can be translated in new or improved contrasts, such as susceptibility-weighted imaging.

fMRI technique is an advanced MR method that benefits from the use of UHF thanks to the positive combination of increased SNR and increased sensitivity to the effect generating the contrast (BOLD effect).

It has been demonstrated that an increase in the spatial resolution of UHF fMRI allows to describe the functional architecture of the cerebral cortex at mesoscopic (sub-millimeter) scale, hence revealing cortical columns-laminar fMRI profiles, and to segment subcortical structures, to explore their functional selectivity to external stimuli and topographic organization, and to study the cortex. Moreover, the increase in the sensitivity of fMRI at 7T allows to obtain statistically significant functional maps of brain activation not only in groups of subjects but also in individual subjects and individual events, opening new perspectives in the use of fMRI for clinical purposes.

The present study aims to use 7T fMRI to understand the mechanisms of the functional organization of the AON circuit, and in particular the relationship between the cerebral cortex and other structures such as the subcortical nuclei and the cerebellum, and to explore how this organization changes in the presence of lesions acquired at an early age, such as in patients with brain lesions that arose in the pre- or perinatal period, like Cerebral Palsy (CP).

We intend to enroll 28 healthy human subjects and 12 adolescents or young adults with CP. All participants will perform a 7 Tesla MRI scan, with a functional and anatomical dedicated protocol and CP patients will have a comprehensive clinical assessment before the MRI exam.

The MR protocol includes 3D MR sequences with very high spatial resolution. In particular, T1-weighted sequences with isotropic voxel size of 0.8mm is used in order to highlight and segment small substructures, but at the same time evaluating the compliance of subjects, especially of patients, in maintaining the position for long acquisition, without introducing motion artifacts. Analogously, 3D FLAIR sequences are acquired for a detailed study of lesions in CP patients.

fMRI acquisitions in humans are carried out by using Gradient-Echo Echo-Planar Imaging (GRE-EPI) sequences with spatial resolutions depending on the target of each functional series and by using imaging acceleration techniques as SENSE and multi-band approaches. For the study of functional connectivity and the whole AON circuit, comprehensive of the cerebellum, we will privilege whole brain coverage and relatively short temporal resolution (1-1.5 seconds), with a spatial resolution of 1.5mm isotropic voxel. On the other hand, for small substructures and laminar column studies, we will optimize an fMRI acquisition with isotropic voxel size of 0.7-0.9mm.

As functional task we use paradigms already described in previous studies and adapted for the 7T scanner.

Visual stimuli are presented in binocular vision by means of Liquid Cristal Display (LCD) goggles (VisuaStim-SVGA-Resonance Technology, USA). Participants observe short video-clips (lasting 4 s each), showing unimanual or bimanual actions performed by an actor, from a subjective perspective. The observed actions consist in grasping and using different tools (e.g., hammering, using a screwdriver, opening a jar etc.) or, as control condition, observation of the static initial frame of each clip. The objects are of different colors in order to avoid visual adaptation. The visual characteristics of each video are balanced between the experimental conditions to control the effects of brightness, contrast, sharpness and amount of visual information. During the rest period, in the absence of experimental stimuli, the participant have to fixate a white cross on a black background. During the entire fMRI acquisition, subject's performance are visually checked by the experimenter and kinematic parameters are recorded by using MR-compatible cameras.

03

Conditions studied

  • Brain Function
  • Cerebral Palsy

Browse trials for

Keywords

  • magnetic resonance imaging
  • ultra high field
  • action observation network
  • cerebral palsy
  • functional re-organization
  • neural plasticity
04

Who can participate

Ages eligible
11 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

primary care clinic for CP; community sample for HC.

Eligibility criteria

For CP patients

Inclusion Criteria:

  • Patients with pre-, peri- or post-natal brain injury, documented by a previous MRI examination of the brain;
  • Intellectual development within the norm or within the mild deficit area, to guarantee understanding and cooperation in the 7T fMRI study;
  • Understanding of the Italian language;

Exclusion Criteria:

  • to performing the 7T fMRI exam;
  • Neuropsychiatric comorbidity that precludes collaboration in the 7T fMRI study;
  • Lack of capacity to understand and to will;
  • Pregnancy;

For Healthy Controls

Inclusion Criteria:

  • Absence of known neurological and psychiatric pathologies;
  • Understanding of the Italian language;

Exclusion Criteria:

  • Contraindications to performing the 7T fMRI exam;
  • Neuropsychiatric comorbidity that precludes collaboration in the 7T fMRI study;
  • Lack of capacity to understand and to will;
  • Pregnancy;
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
40 participants (estimated)
Patient registry
No

Groups and cohorts

  • Healthy Controls

    Subject without any known neurological and psychiatric pathologies

    Other: 7T MR exam

  • CP patients

    Patients with pre-, peri- or post-natal brain injury, as documented in a previous brain MRI examination

    Other: 7T MR exam · Other: clinical assessment

Interventions

  • Other7T MR exam

    a 7 Tesla MRI scan, with a functional and anatomical dedicated protocol

  • Otherclinical assessment

    A comprehensive clinical assessment before the MRI exam.

06

What researchers measure

Primary outcomes

  1. 7T activation maps of the AON

    volume (in cubic millimeters), coordinates (in millimeters), and percentage of signal change of the cortical, subcortical and cerebellar areas elicited by the observation of goal-directed actions

    Time frame: Day 0

  2. 7T connectivity maps of the AON

    correlation between each pair of the cortical, subcortical and cerebellar areas elicited by the observation of goal-directed actions

    Time frame: Day 0

Secondary outcomes

  1. reproducibility

    percentage of healthy subjects in which it is possible to identify the AON circuit

    Time frame: Day 0

  2. clinical correlation

    correlation between characteristics of activations (described as primary outcomes) and clinical assessment

    Time frame: Day 0

07

Study locations

1 of 2 sites recruiting
  • Fondazione IMAGO7
    Calambrone, Pisa 56018, Italy
    Active, not recruiting

    Not enrolling at this site.

  • IRCCS Fondazione Stella Maris
    Calambrone, Pisa 56018, Italy
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided — To be decided, verifying the compliance with European General Data Protection Regulation (GDPR) law

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Dec 2024 (actual). Primary completion is estimated for Aug 2025, 8 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 22, 2025
First posted
Feb 13, 2025
StartActual
Dec 2, 2024
Primary completionEst.
Aug 9, 2025
CompletionEst.
Aug 9, 2025
Last update
Feb 13, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 13, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06826287
Lead sponsor
IRCCS Fondazione Stella Maris
Collaborators
University of Parma, Fondazione IMAGO7
Responsible party
Sponsor
First posted
Feb 13, 2025
Start date
Dec 2, 2024
Primary completion
Aug 9, 2025 (estimated)
Completion
Aug 9, 2025 (estimated)
Last update
Feb 13, 2025

Study contacts

Laura Biagi, PhD
Contact
laura.biagi@fsm.unipi.it
+39050886175
Giuseppina Sgandurra, MD
Contact
giuseppina.sgandurra@fsm.unipi.it
+39050886336
Laura Biagi, PhD
principal investigator · IRCCS Stella Maris

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion